Advance in lung cancer treatment: 81% reduction in progression
Sunday 6/30/2024/Last update 0:27In a major advance for the treatment of advanced non-small cell lung…
0 Comments
Breakthrough in lung cancer treatment: 81% decrease in progression
In a major advance for the treatment of advanced non-small cell lung cancer (NSCLC), Pfizer…
0 Comments
60% of patients with advanced lung cancer live more than 5 years without disease progression
New research released in recent days indicates that 60% of patients with ALK-positive advanced lung…
0 Comments